세계의 알레르기성 결막염 시장 리포트(2023년)

“Allergy Conjunctivitis Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on allergy conjunctivitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for allergy conjunctivitis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The allergy conjunctivitis market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Drug Class: Antihistamines and Mast Cell Stabilizers; Corticosteroids; Other Drug Classes

• 2) By Disease Type: Mild; Severe

• 3) By Distribution Channel: Hospital Pharmacies; Drug Stores and Retail Pharmacies; Online Pharmacies

• Companies Mentioned: Allergan plc.; Santen Pharmaceutical Co Ltd.; Bausch & Lomb Incorporated; Novartis AG; Sun Pharmaceutical Industries Ltd.

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the allergy conjunctivitis market are Allergan plc., Santen Pharmaceutical Co Ltd., Bausch & Lomb Incorporated, Novartis AG, Sun Pharmaceutical Industries Ltd., Ocular Therapeutix Inc., Alcon, Eton Pharmaceutical, AbbVie Inc., Ajanta Pharma Limited, Akron Operating Company LLC, Alembic Pharmaceuticals Ltd., Cipla Ltd., Grevis Pharmaceutical Private Limited, Indoco RemediesLtd., Jabs Biotech Pvt. Ltd., JAWA Pharmaceuticals Pvt. Ltd., Auven Therapeutics, and Atopix Therapeutics Ltd.

The global allergy conjunctivitis market is expected to grow from $2.12 billion in 2022 to $2.27 billion in 2023 at a compound annual growth rate (CAGR) of 5.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The allergy conjunctivitis market is expected to grow to $2.93 billion in 2027 at a CAGR of 5.1%.

The allergy conjunctivitis market consists of sales of therapeutics that are used to treat inflammation of eyes caused due to allergens. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Allergy conjunctivitis is inflammation of the lining of the eye (conjunctiva) which is caused by an allergic reaction to substances like pollen or mold spores. Conjunctiva is the membrane or tissue that covers the inside of eyelids, as well as the white part of the eyeball. Symptoms of allergic conjunctivitis includes red, itchy, and watery eyes.

North America was the largest region in the allergy conjunctivitis market in 2022. The regions covered in the allergy conjunctivitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main drug class of allergy conjunctivitis are antihistamines and mast cell stabilizers, corticosteroids, and others. Antihistamine and mast cell stabilizers are prescriptions or over-the-counter medications that inhibit the physiological action of histamines. The diseases involved are mild and severe whose conjunctivitis are distributed through hospital pharmacies, drug stores, and retail pharmacies, and online pharmacies.

The rise in exposure to air pollutants and chemicals is expected to boost the growth of the allergy conjunctivitis market going forward. Human eyes, one of the most sensitive parts of the human body, are constantly at risk due to ongoing exposure to the poisons in air pollution. Long-term exposure to airborne pollutants and chemicals causes a variety of eye issues, including allergic conjunctivitis, allergies, burning, watering, blurred vision, redness, itching, and persistent discomfort, requiring treatments. For instance, according to the United States Environmental Protection Agency (EPA), an independent executive agency of the United States federal government tasked with environmental protection matters, in the United States, around 67 million tons of pollutants were released into the atmosphere in 2021. Therefore, the rise in exposure to air pollutants and chemicals is driving the growth of the allergy conjunctivitis market.

Product innovation is the key trend gaining popularity in the allergy conjunctivitis market. Major companies operating in the allergy conjunctivitis market are focused on developing innovative and advanced products to strengthen their market position. For instance, in February 2020, Alcon, a US-based medical company specializing in eye care products launched Pataday, the eye allergy drop. The Pataday brand contains the no. 1 doctor-prescribed eye allergy itch relief ingredient and the first once-daily allergy itch relief drop that is available without a prescription. In time for the start of the spring allergy season, Pataday Once Daily Relief and Pataday Twice Daily Relief will be commercially available in the United States. These medications will be sold in all significant mass-market, drug, and grocery stores nationwide (more than 40,000 locations), as well as online. A multimillion-dollar media strategy supporting the launch includes a national TV advertising campaign and a strong web presence to reach people who suffer from eye allergies.

In September 2020, Santen Holdings U.S. Inc., a US-based pharmaceutical company and subsidiary of Santen Pharmaceutical, a Japan-based pharmaceutical company, specializing in ophthalmology, acquired Eyevance Pharmaceuticals LLC for an amount of $225 million. This acquisition enables Santan to expand its global reach and move into the US pharmaceuticals industry. Eyevance Pharmaceuticals LLC is a US-based pharmaceutical company that develops and commercializes topical ophthalmic products targeting the ocular surface and anterior segment.

The countries covered in the allergy conjunctivitis market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The allergy conjunctivitis market research report is one of a series of new reports from The Business Research Company that provides allergy conjunctivitis market statistics, including allergy conjunctivitis industry global market size, regional shares, competitors with allergy conjunctivitis market share, detailed allergy conjunctivitis market segments, market trends, and opportunities, and any further data you may need to thrive in the allergy conjunctivitis industry. This allergy conjunctivitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Table of Contents

1. Executive Summary

2. Allergy Conjunctivitis Market Characteristics

3. Allergy Conjunctivitis Market Trends And Strategies

4. Allergy Conjunctivitis Market - Macro Economic Scenario

• 4.1. COVID-19 Impact On Allergy Conjunctivitis Market
• 4.2. Ukraine-Russia War Impact On Allergy Conjunctivitis Market
• 4.3. Impact Of High Inflation On Allergy Conjunctivitis Market

5. Allergy Conjunctivitis Market Size And Growth

• 5.1. Global Allergy Conjunctivitis Historic Market, 2017-2022, $ Billion
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints On The Market
• 5.2. Global Allergy Conjunctivitis Forecast Market, 2022-2027F, 2032F, $ Billion
  • 5.2.1. Drivers Of The Market
  • 5.2.2. Restraints On the Market

6. Allergy Conjunctivitis Market Segmentation

• 6.1. Global Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Antihistamines And Mast Cell Stabilizers
• Corticosteroids
• Other Drug Classes
• 6.2. Global Allergy Conjunctivitis Market, Segmentation By Disease Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Mild
• Severe
• 6.3. Global Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Hospital Pharmacies
• Drug Stores And Retail Pharmacies
• Online Pharmacies

7. Allergy Conjunctivitis Market Regional And Country Analysis

• 7.1. Global Allergy Conjunctivitis Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 7.2. Global Allergy Conjunctivitis Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Allergy Conjunctivitis Market

• 8.1. Asia-Pacific Allergy Conjunctivitis Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 8.3. Asia-Pacific Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Allergy Conjunctivitis Market

• 9.1. China Allergy Conjunctivitis Market Overview
• 9.2. China Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
• 9.3. China Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Allergy Conjunctivitis Market

• 10.1. India Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 10.2. India Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Allergy Conjunctivitis Market

• 11.1. Japan Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 11.2. Japan Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Allergy Conjunctivitis Market

• 12.1. Australia Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 12.2. Australia Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Allergy Conjunctivitis Market

• 13.1. Indonesia Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 13.2. Indonesia Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Allergy Conjunctivitis Market

• 14.1. South Korea Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 14.2. South Korea Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Allergy Conjunctivitis Market

• 15.1. Western Europe Allergy Conjunctivitis Market Overview
• 15.2. Western Europe Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 15.3. Western Europe Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Allergy Conjunctivitis Market

• 16.1. UK Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 16.2. UK Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Allergy Conjunctivitis Market

• 17.1. Germany Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 17.2. Germany Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Allergy Conjunctivitis Market

• 18.1. France Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 18.2. France Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Allergy Conjunctivitis Market

• 19.1. Eastern Europe Allergy Conjunctivitis Market Overview
• 19.2. Eastern Europe Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 19.3. Eastern Europe Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Allergy Conjunctivitis Market

• 20.1. Russia Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 20.2. Russia Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Allergy Conjunctivitis Market

• 21.1. North America Allergy Conjunctivitis Market Overview
• 21.2. North America Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 21.3. North America Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Allergy Conjunctivitis Market

• 22.1. USA Allergy Conjunctivitis Market Overview
• 22.2. USA Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 22.3. USA Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Allergy Conjunctivitis Market

• 23.1. South America Allergy Conjunctivitis Market Overview
• 23.2. South America Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 23.3. South America Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Allergy Conjunctivitis Market

• 24.1. Brazil Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 24.2. Brazil Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Allergy Conjunctivitis Market

• 25.1. Middle East Allergy Conjunctivitis Market Overview
• 25.2. Middle East Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 25.3. Middle East Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Allergy Conjunctivitis Market

• 26.1. Africa Allergy Conjunctivitis Market Overview
• 26.2. Africa Allergy Conjunctivitis Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 26.3. Africa Allergy Conjunctivitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Allergy Conjunctivitis Market Competitive Landscape And Company Profiles

• 27.1. Allergy Conjunctivitis Market Competitive Landscape
• 27.2. Allergy Conjunctivitis Market Company Profiles
  • 27.2.1. Allergan plc.
    • 27.2.1.1. Overview
    • 27.2.1.2. Products and Services
    • 27.2.1.3. Strategy
    • 27.2.1.4. Financial Performance
  • 27.2.2. Santen Pharmaceutical Co Ltd.
    • 27.2.2.1. Overview
    • 27.2.2.2. Products and Services
    • 27.2.2.3. Strategy
    • 27.2.2.4. Financial Performance
  • 27.2.3. Bausch & Lomb Incorporated
    • 27.2.3.1. Overview
    • 27.2.3.2. Products and Services
    • 27.2.3.3. Strategy
    • 27.2.3.4. Financial Performance
  • 27.2.4. Novartis AG
    • 27.2.4.1. Overview
    • 27.2.4.2. Products and Services
    • 27.2.4.3. Strategy
    • 27.2.4.4. Financial Performance
  • 27.2.5. Sun Pharmaceutical Industries Ltd.
    • 27.2.5.1. Overview
    • 27.2.5.2. Products and Services
    • 27.2.5.3. Strategy
    • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Allergy Conjunctivitis Market

29. Allergy Conjunctivitis Market Future Outlook and Potential Analysis

30. Appendix

• 30.1. Abbreviations
• 30.2. Currencies
• 30.3. Historic And Forecast Inflation Rates
• 30.4. Research Inquiries
• 30.5. The Business Research Company
• 30.6. Copyright And Disclaimer